Report – Key Insights from CDER Warning Letters: Hot Topics and Trends

A Data-Driven Look at the FDA’s Most Pressing Compliance Concerns

This report provides a comprehensive analysis of FDA CDER GMP Warning Letters issued in 2024 and early 2025, helping Quality, Regulatory, and Site Operations teams benchmark their compliance programs against current enforcement priorities.

Leveraging Redica’s enhanced intelligence tools and data, the report highlights key deficiencies, real-world case studies, and evolving trends to help you anticipate risk and strengthen your quality systems.

Download your copy of the report to uncover the patterns driving enforcement activity and take proactive steps toward stronger compliance.